azides has been researched along with Encephalitis, Venezuelan Equine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakken, RR; Cohen, JW; Eccleston, LT; Glass, PJ; Gupta, P; Honnold, SP; Maheshwari, RK; Sharma, A; Spurgers, KB | 1 |
| Glass, PJ; Gupta, P; Maheshwari, RK; Parker, MD; Sharma, A | 1 |
2 other study(ies) available for azides and Encephalitis, Venezuelan Equine
| Article | Year |
|---|---|
1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Topics: Aerosols; Animals; Antibodies, Viral; Azides; Encephalitis Virus, Venezuelan Equine; Encephalomyelitis, Venezuelan Equine; Immunoglobulin G; Mice; Neutralization Tests; Vaccination; Vaccines, Inactivated; Viral Vaccines | 2016 |
Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development.
Topics: Animals; Azides; Cytopathogenic Effect, Viral; Disease Models, Animal; Disinfectants; Encephalitis Virus, Venezuelan Equine; Encephalomyelitis, Venezuelan Equine; Mice; Microbial Viability; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Survival Analysis; Vaccines, Inactivated; Viral Plaque Assay; Viral Vaccines; Virulence; Virus Inactivation | 2011 |